Omaxe Analyst Review May 2026
- May 19, 2026
- Posted by: Neeraj Pandey
- Category: News
This Omaxe analyst review for May 2026 covers the key data investors need for OMAXE at its current price of Rs 198. Omaxe (NSE: OMAXE) is a real estate developer with a market capitalisation of approximately Rs 2,800 crore, focused on residential townships and integrated developments in North India. The analyst consensus target of Rs 235 implies meaningful upside, and this Omaxe analyst review examines technical levels, business segments, valuation, and key risks for OMAXE through FY27.
Click Here – Get Free Investment Predictions
Omaxe Company Snapshot May 2026
Omaxe’s integrated townships in Uttar Pradesh, Rajasthan, Punjab, and Haryana target the affordable and mid-segment residential buyer. The New Chandigarh and Lucknow township projects are the largest ongoing developments. The table below summarises the key data referenced in this Omaxe analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | OMAXE |
| Sector | Real Estate – Residential and Commercial |
| CMP (May 2026) | Rs 198 |
| 52 Week High | Rs 298 |
| 52 Week Low | Rs 168 |
| Market Cap | Rs 2,800 Crore |
| Trailing P/E | NAx |
| Analyst Consensus Target | Rs 235 |
| Bull Case Target | Rs 310 |
| Bear Case Target | Rs 165 |
Analyst Insight in This Omaxe Analyst Review
Associate Director Kunal Singla suggests watching Omaxe closely in May 2026. At Rs 198, Kunal Singla flags Real Estate – Residential and Commercial sector dynamics as the primary driver for OMAXE’s near-term price action. He notes support in the Rs 171 to Rs 188 zone and flags any sustained close above Rs 210 as a positive signal. Kunal Singla’s perspective on Omaxe adds professional analysis to this Omaxe analyst review and is not a buy recommendation.
Technical Analysis in This Omaxe Analyst Review
At Rs 198, OMAXE is trading within its 52-week band of Rs 168 to Rs 298. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 171 to Rs 188 band while resistance is seen in the Rs 210 to Rs 216 zone. A sustained move above Rs 210 could open the path toward the analyst consensus target of Rs 235 as outlined in this Omaxe analyst review.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 171 to Rs 188 – investors tracking this Omaxe analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for OMAXE.
- Resistance Zone: Rs 210 to Rs 216 – a sustained close above Rs 210 would be a positive breakout signal worth flagging in this Omaxe analyst review.
- Medium-Term Target: The analyst consensus of Rs 235 represents the base-case upside scenario in this Omaxe analyst review.
Business Segment Analysis
Integrated Residential Townships (North India)
This is the primary revenue and margin driver for Omaxe, directly supporting the earnings trajectory toward the consensus target of Rs 235.
Commercial Complexes and Shopping Malls
This segment adds scale and diversification to Omaxe’s business model and is a meaningful EPS contributor through FY27 and FY28.
Plots and Plotted Developments
This represents the medium-term growth frontier for Omaxe and a key re-rating catalyst over the next 12 to 24 months.
Valuation in This Omaxe Analyst Review
At Rs 198, Omaxe trades at a trailing P/E of NAx. This Omaxe analyst review presents three scenarios: a bull case of Rs 310 on strong earnings delivery and sector tailwinds, a base case of Rs 235 at analyst consensus, and a bear case of Rs 165 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Omaxe analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 310 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 235 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 165 | Earnings miss or macro headwinds |
Trade Outlook for Omaxe
Based on the technical and fundamental analysis in this Omaxe analyst review, investors might watch OMAXE near the support zone of Rs 171 to Rs 188 for potential opportunities. A flag above Rs 210 could suggest improving momentum toward Rs 235. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Omaxe in FY27
A well-rounded Omaxe analyst review must assess downside risks. Key risks for Omaxe include a macro slowdown affecting Real Estate – Residential and Commercial sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in OMAXE.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Omaxe Analyst Review Verdict for 2026
This Omaxe analyst review concludes that at Rs 198, OMAXE offers a defined risk-reward with a consensus target of Rs 235. The 52-week range of Rs 168 to Rs 298 provides context on the current entry point. Use this Omaxe analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on OMAXE.
Frequently Asked Questions: Omaxe Analyst Review 2026
What is the analyst target for Omaxe in 2026?
The analyst consensus target is Rs 235, with a bull case of Rs 310 and a bear case of Rs 165. This Omaxe analyst review recommends monitoring Q1 FY27 earnings for confirmation.
Is Omaxe a good investment at Rs 198?
At Rs 198 with a P/E of NAx and a consensus target of Rs 235, this Omaxe analyst review is constructive for medium to long-term investors in the Real Estate – Residential and Commercial sector. Always consult a SEBI-registered advisor before investing.
What is Omaxe’s 52-week high and low?
The 52-week high is Rs 298 and the 52-week low is Rs 168. At Rs 198, OMAXE is positioned within this range as detailed in this Omaxe analyst review.
What are the key risks for Omaxe?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Real Estate – Residential and Commercial sector, all assessed in this Omaxe analyst review.
Where can I track live data for Omaxe?
Track Omaxe’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Omaxe analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
